Oxford Nanopore Technologies (LON:ONT) Insider Acquires £149.60 in Stock

Key Points

• Nick Keher, an insider, purchased 136 shares on April 14 at GBX 110 per share for a total of £149.60.
• He has made four small purchases since January—100 shares at GBX 150 (Jan), 105 at GBX 143 (Feb), 121 at GBX 124 (Mar), and 136 at GBX 110 (Apr)—indicating repeated insider buying at progressively lower prices.
• ONT shares rose about 4.5% to GBX 110.10 on the day; the company is currently loss-making (negative EPS and margins), has a market cap of ~£1.07bn, and a consensus "Moderate Buy" with an average target of GBX 218.60.

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) insider Nick Keher purchased 136 shares of the business's stock in a transaction that occurred on Tuesday, April 14th. The stock was bought at an average price of GBX 110 per share, with a total value of £149.60.

Nick Keher also recently made the following trade(s):

• On Thursday, March 12th, Nick Keher bought 121 shares of Oxford Nanopore Technologies stock. The shares were acquired at an average price of GBX 124 per share, with a total value of £150.04.
• On Thursday, February 12th, Nick Keher purchased 105 shares of Oxford Nanopore Technologies stock. The stock was purchased at an average price of GBX 143 per share, with a total value of £150.15.
• On Wednesday, January 14th, Nick Keher acquired 100 shares of Oxford Nanopore Technologies stock. The stock was bought at an average price of GBX 150 per share, with a total value of £150.

Oxford Nanopore Technologies Trading Up 4.5%

Shares of LON ONT traded up GBX 4.70 during midday trading on Tuesday, reaching GBX 110.10. The stock had a trading volume of 3,916,681 shares, compared to its average volume of 10,023,564. The company has a debt-to-equity ratio of 8.96, a quick ratio of 6.01 and a current ratio of 3.56. The company's 50 day moving average price is GBX 124.81 and its 200 day moving average price is GBX 134.82. Oxford Nanopore Technologies plc has a twelve month low of GBX 104 and a twelve month high of GBX 224.80. The firm has a market cap of £1.07 billion, a price-to-earnings ratio of -7.29 and a beta of 0.88.

Oxford Nanopore Technologies (LON:ONT - Get Free Report) last issued its earnings results on Monday, March 2nd. The company reported GBX (15.10) EPS for the quarter. Oxford Nanopore Technologies had a negative net margin of 64.85% and a negative return on equity of 29.43%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on ONT shares. Berenberg Bank reissued a "buy" rating and issued a GBX 250 target price on shares of Oxford Nanopore Technologies in a research note on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Oxford Nanopore Technologies from GBX 210 to GBX 225 and gave the company a "buy" rating in a report on Thursday, January 22nd. Finally, Royal Bank Of Canada lowered their price objective on shares of Oxford Nanopore Technologies from GBX 300 to GBX 225 and set an "outperform" rating for the company in a research report on Tuesday, March 24th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of GBX 218.60.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.